CompletedPhase 4

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines

United Kingdom392 participantsStarted 2005-04

Plain-language summary

The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjugate vaccine given at either two and three or two and four months of age.

Who can participate

Age range7 Weeks – 11 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Written informed consent obtained from parent or legal guardian of infant * Age 7-11 weeks at first dose Exclusion Criteria: * Any contraindications to vaccination as specified in the UK Handbook "Immunisation Against Infectious Disease" (Ed 1996) * \< 7 weeks or \> 11 weeks at first dose

What they're measuring

Immunogenicity

Timeframe: 3 months after last sample

Trial details

NCT IDNCT00197808

SponsorPublic Health England

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2010-01

View on ClinicalTrials.gov More Pneumococcal Infections trials